These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19921781)

  • 1. Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity.
    Frost JM; Dart MJ; Tietje KR; Garrison TR; Grayson GK; Daza AV; El-Kouhen OF; Yao BB; Hsieh GC; Pai M; Zhu CZ; Chandran P; Meyer MD
    J Med Chem; 2010 Jan; 53(1):295-315. PubMed ID: 19921781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity.
    Frost JM; Dart MJ; Tietje KR; Garrison TR; Grayson GK; Daza AV; El-Kouhen OF; Miller LN; Li L; Yao BB; Hsieh GC; Pai M; Zhu CZ; Chandran P; Meyer MD
    J Med Chem; 2008 Mar; 51(6):1904-12. PubMed ID: 18311894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles.
    Huffman JW; Szklennik PV; Almond A; Bushell K; Selley DE; He H; Cassidy MP; Wiley JL; Martin BR
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4110-3. PubMed ID: 16005223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.
    Stern E; Muccioli GG; Millet R; Goossens JF; Farce A; Chavatte P; Poupaert JH; Lambert DM; Depreux P; Hénichart JP
    J Med Chem; 2006 Jan; 49(1):70-9. PubMed ID: 16392793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: design, synthesis, structure-activity relationships, physicochemical properties and biological activity.
    Blaazer AR; Lange JH; van der Neut MA; Mulder A; den Boon FS; Werkman TR; Kruse CG; Wadman WJ
    Eur J Med Chem; 2011 Oct; 46(10):5086-98. PubMed ID: 21885167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of quinolinyl and isoquinolinyl phenyl ketones as novel agonists for the cannabinoid CB2 receptor.
    Reux B; Nevalainen T; Raitio KH; Koskinen AM
    Bioorg Med Chem; 2009 Jul; 17(13):4441-7. PubMed ID: 19477133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of CoMFA and CoMSIA models of affinity and selectivity for indole ligands of cannabinoid CB1 and CB2 receptors.
    De Freitas GB; da Silva LL; Romeiro NC; Fraga CA
    Eur J Med Chem; 2009 Jun; 44(6):2482-96. PubMed ID: 19249138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonamide derivatives as new potent and selective CB2 cannabinoid receptor agonists.
    Ohta H; Ishizaka T; Yoshinaga M; Morita A; Tomishima Y; Toda Y; Saito S
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5133-5. PubMed ID: 17643986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors.
    Huffman JW; Padgett LW; Isherwood ML; Wiley JL; Martin BR
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5432-5. PubMed ID: 16889960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor.
    Deng H; Gifford AN; Zvonok AM; Cui G; Li X; Fan P; Deschamps JR; Flippen-Anderson JL; Gatley SJ; Makriyannis A
    J Med Chem; 2005 Oct; 48(20):6386-92. PubMed ID: 16190764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel class of selective human CB1 inverse agonists.
    Foloppe N; Allen NH; Bentley CH; Brooks TD; Kennett G; Knight AR; Leonardi S; Misra A; Monck NJ; Sellwood DM
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1199-206. PubMed ID: 18083560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonists.
    Manera C; Saccomanni G; Adinolfi B; Benetti V; Ligresti A; Cascio MG; Tuccinardi T; Lucchesi V; Martinelli A; Nieri P; Masini E; Di Marzo V; Ferrarini PL
    J Med Chem; 2009 Jun; 52(12):3644-51. PubMed ID: 19435366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors.
    Pasquini S; De Rosa M; Ligresti A; Mugnaini C; Brizzi A; Caradonna NP; Cascio MG; Bolognini D; Pertwee RG; Di Marzo V; Corelli F
    Eur J Med Chem; 2012 Dec; 58():30-43. PubMed ID: 23085772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.
    Behrenswerth A; Volz N; Toräng J; Hinz S; Bräse S; Müller CE
    Bioorg Med Chem; 2009 Apr; 17(7):2842-51. PubMed ID: 19278853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.
    Durdagi S; Kapou A; Kourouli T; Andreou T; Nikas SP; Nahmias VR; Papahatjis DP; Papadopoulos MG; Mavromoustakos T
    J Med Chem; 2007 Jun; 50(12):2875-85. PubMed ID: 17521177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and structure-activity relationship study of conformationally constrained analogs of indole-3-carboxamides as novel CB1 cannabinoid receptor agonists.
    Kiyoi T; York M; Francis S; Edwards D; Walker G; Houghton AK; Cottney JE; Baker J; Adam JM
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4918-21. PubMed ID: 20634067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor.
    Moloney GP; Angus JA; Robertson AD; Stoermer MJ; Robinson M; Wright CE; McRae K; Christopoulos A
    Eur J Med Chem; 2008 Mar; 43(3):513-39. PubMed ID: 17582659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and activity of 1,3,5-triphenylimidazolidine-2,4-diones and 1,3,5-triphenyl-2-thioxoimidazolidin-4-ones: characterization of new CB1 cannabinoid receptor inverse agonists/antagonists.
    Muccioli GG; Wouters J; Charlier C; Scriba GK; Pizza T; Di Pace P; De Martino P; Poppitz W; Poupaert JH; Lambert DM
    J Med Chem; 2006 Feb; 49(3):872-82. PubMed ID: 16451053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
    Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
    Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 1,2,3,4-tetrahydropyrrolo[3,4-b]indole derivatives as selective CB2 receptor agonists.
    Pagé D; Yang H; Brown W; Walpole C; Fleurent M; Fyfe M; Gaudreault F; St-Onge S
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6183-7. PubMed ID: 17884494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.